循证医学(Evidence-based Medicine)——临床研究与实践的新时代

被引:6
作者
胡大一
机构
[1] 首都医科大学附属北京红十字朝阳医院心脏中心北京
关键词
循证医学; 临床试验; 药物评价;
D O I
暂无
中图分类号
R-0 [一般理论];
学科分类号
1001 ;
摘要
80年代以来的大规模、随机、双盲、多中心、安慰剂对照临床试验证明,以经验和推论,如以一些临床化验指标为依据的传统临床试验不能反映病人的长期预后。为了对新药和已上市药物作出恰当的评价,应当从所谓“众说纷坛”转向注重和评价病人预后,包括总死亡率、重要心脑血管事件、生活质量、卫生经济学等的“循证医学”。反过来,“循证医学”和临床治疗指南的发展将对新药的研究与开发、医生的临床实践、药物经济学、医疗保健服务决策等带来积极和正面的影响。
引用
收藏
页码:6 / 8
页数:3
相关论文
共 9 条
[1]  
Design features and baseline characteristics of the LIPID Study: a randomized trial in patients with previous acute myocardial infarction and/or unstable angina pectoris. The LIPID Study Group. The American Journal of Cardiology . 1995
[2]  
Oral captopril versus placebo among 13 634 patients with suspected acute myocardial infarction: interim report from the Chinese Cardiac study (CCS-1 ). hinese Cardiac Study Collaborative Group. The Lancet . 1995
[3]  
Randomized trial of cholesterol lowering in 4 444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). The Scandinavian Simvastatin Survival Study Group. The Lancet . 1994
[4]  
An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. The GUSTO investigators. The New England Journal of Medicine . 1993
[5]  
Effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non-Q-wave myocardial infarction.Results of the TIMI-Ⅲ B trial. The TIMI-Ⅲ B investigators. Circulation . 1994
[6]  
Effect of prophylactic amiodarone on mortality after acute myocardial infarction and in congestive heart failure: meta-analysis of individual data from 6 500 patients in randomized trials. Amiodarone Trial Meta-analysis Investigators. The Lancet . 1997
[7]  
Cardiac Arrhythmia Suppression Tril. Echt DS,Leibson PR,Mitchel LB,et al. The New England Journal of Medicine . 1989
[8]  
Early effects of tissue-type plasminogen activator added to convention therapy on the culprit coronary lesion in patients presenting with ischemic cardiac pain at rest.Results of the thrombolysis in myocardial ischemia (TIMI Ⅱ A) trial. The TIMI-Ⅱ A investigators. Circulation . 1993
[9]  
The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Sacki FM,Pfeffer MA,Moye LA,et al. The New England Journal of Medicine . 1996